William Pridgen, Director at Virios Therapeutics, Inc. (VIRI), bought 241 shares at $4.50 ($1K) on 2022-05-18, disclosed to the SEC on 2022-05-19.
Open-market purchase of $1k VIRI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| VIRI | BUY | 2022-03-30 | $3K | — | Filing → |
| VIRI | BUY | 2022-03-24 | $12K | — | Filing → |
| VIRI | BUY | 2022-01-28 | $25K | — | Filing → |